Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. TASMAR (tolcapone)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

TASMAR (tolcapone)

Medicine - Posted on Feb 08 2016 - Updated on Jun 12 2019
Active substance (DCI)
  • tolcapone
history (3)
  • 1/20/16

    TASMAR (tolcapone)

    Maintien du remboursement dans les mêmes conditions
    icône flèche
  • 2/2/11

    TASMAR

    TASMAR
    icône flèche
  • 11/2/05

    TASMAR 100 mg, comprimé pelliculé flacon(s) en verre de 100 comprimé(s)(Code CIP : 345 466-4)

    TASMAR 100 mg, comprimé pelliculé flacon(s) en verre de 100 comprimé(s)(Code CIP : 345 466-4)
    icône flèche
Technical information
ATC code
  • N04BX01
Manufacturer
MEDA PHARMA
Presentation

TASMAR 100 mg, comprimé pelliculé (code CIS : 67077388) flacon en verre de 100 comprimés - Code CIP : 3400934546648

All our publications
    Central nervous system diseases Drug therapy Geriatrics Neurodegenerative diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
PwskMAH4YTHBTM2A